| Literature DB >> 27567145 |
Yasmin Chandani1, Malia Duffy2, Barbara Lamphere3, Megan Noel3, Alexis Heaton3, Sarah Andersson3.
Abstract
BACKGROUND: Supply chain bottlenecks that prevent community health workers (CHWs) from accessing essential medicines significantly increase under-5 child mortality, particularly in poor and rural areas.Entities:
Keywords: Community health workers; Integrated community case management; Supply chain management
Mesh:
Substances:
Year: 2016 PMID: 27567145 PMCID: PMC5704638 DOI: 10.1016/j.sapharm.2016.07.003
Source DB: PubMed Journal: Res Social Adm Pharm ISSN: 1551-7411
Fig. 1Five preconditions of community level product availability.
Overview of endline study design by country
| Country | Sampling method | Selection criteria | Data collection | Analysis |
|---|---|---|---|---|
| Rwanda April–June 2014 | ||||
Purposive sampling of 2 health centers in 2 baseline districts | Two original districts were purposively selected based on performance: highest and lowest change in product availability from baseline to midline | 53 in-depth interviews with cell coordinators, CHW supervisors, health center pharmacy managers, district CHW supervisor, and district pharmacist | Interview transcripts and observations were analyzed during workshop to identify emerging themes | |
Purposive sampling of a third baseline health center | Two new districts were purposively selected based on where RSP scale-up had started, QI teams addendum training conducted, the partner support model, and having a health center profile similar to the original districts | 52 observation, demonstration, collective discussions, or photos | Second stage analysis compared original and scale-up districts, identifying institutionalization and formulating lessons from scale-up | |
Purposive sampling of 2 health centers in 2 scale-up districts | Specific themes identified during the workshop were analyzed by different team members and findings were reviewed by the entire team | |||
Random sampling of 30 health centers to match baseline and midline numbers | Randomly selected from QI teams districts | 64 structured interviews with cell coordinator and 96 CHW structured interviews | Chi-square using Stata SE 13 | |
Measurement of tool availability, key activity status, information quality, and product availability | ||||
| Malawi June–July 2014 | ||||
Purposive sampling of 2 health centers in 2 baseline districts | Two original districts were purposively selected based on performance at midline | 24 in-depth interviews with CHWs | Interview transcripts and observations were analyzed during workshop to identify emerging themes | |
Purposive sampling of 2 health centers in 2 scale-up districts | Two new districts were purposively selected; 1 district where cStock was introduced before midline and QI teams were introduced after midline and 1 district where both cStock plus QI teams were introduced after midline | 16 CHW interviews | Second stage analysis compared original and scale-up districts; identifying institutionalization and formulating lessons from scale-up | |
Health centers were purposively selected based on performance (high reporting rates, low and high meeting occurrence) | 15 interviews with program coordinators, district health officers or district medical officers, and pharmacy technicians. | Specific themes identified during the workshop were re-analyzed by different team members and findings reviewed by entire team | ||
22 observations, demonstrations, collective discussions, photos | ||||
All available data in cStock | All CHWs using cStock nationally, plus district level data for case study districts | Data was extracted for stock status, stockouts, reporting rate, order fill rate, and emergency orders for period between midline and endline (January 2013 –– May 2014) | Trend analysis | |
Malawi performance monitoring by district and health center
| Original district | Scale-up districts | |||||||
|---|---|---|---|---|---|---|---|---|
| District A | District B | District C | District D | |||||
| HF 1 | HF 2 | HF 1 | HF 2 | HF 1 | HF 2 | HF 1 | HF 2 | |
| Document used for monitoring | No mention | Report from district | No mention | Resupply worksheet | Resupply worksheet | Resupply worksheet | Form 1A | No mention |
| Performance plan | No | No | No | No | No | No | No | No |
| Management diary | Yes, not observed | Yes* | Yes | Yes | Yes | Yes | Yes | Yes |
| Recognition plan | No | No | No | No | No | No | No | No |
| Indicators discussed during meetings** | ||||||||
| Reporting | n/a | X | X | X | X | X | X | X |
| Lead times | n/a | X | X | X | X | X | ||
| Emergency orders | n/a | X | X | X | ||||
| Stock issues | n/a | X | X | X | X | |||
*Observed management diary entries only from 2011 to August 2013 when meetings were still occurring; **Management diaries observed from November 2013 to June 2014.
Perceived benefits of QI team meetings
| Perceived benefit | Key quotations |
|---|---|
| Enables collective problem solving | |
| Facilitates better performance | |
| Enables knowledge and experience sharing | |
| Allows mutual encouragement and motivation and improved relationships | |
| Increases coordination and collaboration between levels of the health system | |
Perceived challenges related to regular monthly team meetings
| Challenge | Key quotation |
|---|---|
| Transportation/distance | |
| Length of meeting and lack of refreshments/allowances | |
| Other competing obligations | |
| Lack of district engagement and feedback | |
Fig. 2Percent of CHWs in-stock on day of visit.
Fig. 3Average in-stock rates across 5 CCM products.